ロード中...
Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice
A double blind, placebo-controlled phase II study revealed that the antihistamine, Dimebon® (dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients compared to placebo controls. However, the Phase III CONNECTION trial failed to demonstrate significant differences between dime...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3466490/ https://ncbi.nlm.nih.gov/pubmed/23071869 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|